ZyVersa Therapeutics Inc.

NASDAQ: ZVSA · Real-Time Price · USD
0.31
-0.24 (-43.53%)
At close: Jul 16, 2025, 3:59 PM

ZyVersa Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.00 -0.01 -0.02 -18
PEG Ratio
0.00 -0.00 -0.00 0.50
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.00 0.08 0.14 -12.83
P/FCF Ratio
-0.16 -0.1 -9.53 -31.58
P/OCF Ratio
-0.16 -0.1 -9.53 -31.58
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a 0.00 0.00 -0.73
Quick Ratio
0.15 0.33 0.78 0.06
Current Ratio
0.15 0.33 0.78 0.06
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-33.86K 31.56 -30.44 -9.38
Return on Equity
-1.11 -8.88 -7.59 0.71
Return on Assets
-456.98 -4.44 -6.41 -7.91
Return on Invested Capital
-974.61 -1.1 -6.37 2.53
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a